Agilent Technologies (A) vs Revvity (RVTY)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Revvity (RVTY) has outperformed Agilent Technologies (A) over the past year, gaining 68.9% versus a gain of 22.0%. Over five years, A leads with a +10.3% price change compared with -9.3% for RVTY. Agilent Technologies is the larger company by market cap ($46.40 billion vs $16.46 billion), about 2.8 times the size.
On valuation, Agilent Technologies trades at a lower forward P/E (24.3x vs 25.0x for Revvity). Agilent Technologies offers the higher dividend yield (0.62% vs 0.19%). Agilent Technologies converts more of its revenue into profit, with a net margin of 18.8% versus 8.4%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | A | RVTY |
|---|---|---|
| Share price | $164.55 | $147.47 |
| Market cap | $46.40B | $16.46B |
| 1-day change | -2.65% | -3.95% |
| YTD return | +24.27% | +59.21% |
| 1-year return | +22.03% | +68.92% |
| 5-year return | +10.32% | -9.29% |
| P/E ratio (TTM) | 32.46 | 70.56 |
| Forward P/E | 24.35 | 25.02 |
| EPS (TTM) | $5.07 | $2.09 |
| Dividend yield | 0.62% | 0.19% |
| Annual dividend | $1.01 | $0.28 |
| Revenue (latest FY) | $6.95B | $2.86B |
| Revenue growth (YoY) | +6.73% | +3.67% |
| Net income (latest FY) | $1.30B | $241.20M |
| Gross margin | 52.43% | — |
| Operating margin | 21.29% | 12.49% |
| Net margin | 18.75% | 8.45% |
| 52-week high | $177.05 | $166.25 |
| 52-week low | $108.35 | $81.22 |
| Distance from 52-week high | -7.06% | -11.30% |
| Analyst consensus | buy | buy |
| Avg. price target upside | +7.26% | -7.87% |
| Average volume | 2.26M | 1.79M |
| Shares outstanding | 281.97M | 111.59M |
| Employees | 18,200 | 11,000 |
| Sector | Industrials | Industrials |
| Industry | Biotechnology: Laboratory Analytical Instruments | Biotechnology: Laboratory Analytical Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Agilent Technologies is about 2.8 times larger than Revvity by market value ($46.40B vs $16.46B).
- RVTY has outperformed A by 46.9 percentage points over the past year.
- Revvity trades at a higher earnings multiple (70.6x vs 32.5x trailing P/E).
- Agilent Technologies is more profitable, keeping 18.8 cents of every revenue dollar as net income versus 8.4 cents for Revvity.
About Agilent Technologies
A stock →Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide.
Industrials · Biotechnology: Laboratory Analytical Instruments · 18,200 employees
About Revvity
RVTY stock →Revvity, Inc. provides health sciences solutions, technologies, and services.
Industrials · Biotechnology: Laboratory Analytical Instruments · 11,000 employees
A vs RVTY FAQ
Which is bigger, Agilent Technologies or Revvity?
Agilent Technologies (A) is larger, with a market capitalization of $46.40B compared with $16.46B for Revvity (RVTY).
Which stock has performed better over the past year, A or RVTY?
RVTY returned +68.92% over the past 12 months, compared with +22.03% for A (price return, excluding dividends). Past performance does not predict future results.
Which has the lower P/E ratio, A or RVTY?
A has the lower trailing P/E at 32.5, versus 70.6 for RVTY. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.
Which pays a higher dividend, Agilent Technologies or Revvity?
Agilent Technologies has the higher yield at 0.62%, compared with 0.19% for Revvity.
Are Agilent Technologies and Revvity in the same industry?
Yes. Both are classified in the Biotechnology: Laboratory Analytical Instruments industry within the Industrials sector.